AR and cancer: Androgen receptor (AR) signaling could promote the transition from stem cell-like CD8+ T cells to terminally exhausted CD8+ T cells in male mice, and it was correlated with tumor-infiltrating CD8+ T cell exhaustion in cancer patients16.